Publications and conferences
• Boharoon H, Tomlinson J, Limback-Stanic C, Gontsorova A, Martin N, Hatfield E, Meeran K, Nair R, Mendoza N, Levy J, McAdoo S, Pusey C, Wernig F. A Case series of Patients with Isolated IgG4- related Hypophysitis treated with Rituximab. Journal of the Endocrine Society. Accepted Maunscript, published 21 April 2020• Clarke S, Abbara A, Brewster R, Simmonard A, Eng PC, Phylactou M, Papadopoulou D, Izzi- Engbeaya D, Sam A, Wernig F, Jonauskyte E, Comninos A, Meeran K, Kelsey T, Dhillo W. CasePharacodynamic response to anti-thyroid drugs in Graves’ hyperthyroidism. Frontiers in Endocrinology. 12 May 2020.
• Marques P, Caimari F, Hernandez-Ramirez LC, Collier D, Iacovazzo D, Ronaldson A, Magdid K, Lim CT, Stals K, Ellard S, Grossman AB, Korbonits M; FIPA Consortium: Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-Onset Pituitary Tumors. J Clin Endocrinol Metab. Jun 2020; 105(6)• Zaman S, Patel B, Glynne P, Vanderpump M, Alsafi A, Khan S, Flora R Palazzo F, Wernig F: A rare cause of severe Cushing’s syndrome. Endocrinol Diabetes Metab Case Rep. Mar 13, 2020• Marques P, Stelmachowska-Banas M, Collier D, Wernig F, Korbonits M: Pachydermoperiostosis mimicking the acral abnormalities of acromegaly. Endocrine. Feb 2020; 67(2):499-500.• Sharma R, Wang WM, Yusuf S Evans J, Ramaswami R, Wernig F, Frilling A, Mauri F, Al-Nahhas A, Aboagye EO, Barwick TD: 68Ga-D”OTATATE PET/CT parameters predict response to peptide receptor radionuclide therapy in neuroendocrine tumours. Radiother Oncol. Dec 2019; 141:108-115• Poo SX, Tham CSW, Smit C, Lee J, Cairns T, Galliford J, Hamdulay S, Jacyna M, Levy JB, McAdoo SP, Roufosse C, Wernig F, Mason JC, Pusey CD, Tam FWK, Tomlinson JAP: IgG4-related disease in a multi-ethnic community:clinical characteristics and association with malignancy. QJM. Oct 2019; 112(10):763-769• Pearce SHS, Dayan C, Wraith DC, Barrell K, Olive N, Jansson L, Walker-Smit T, Carnegie C, Martin KF, Boelaert K, Gilbert J, Higham CE, Muller I, Murray RD, Perros P, Razvi S, Vaidya B, Wernig F, Kahaly GJ: Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves’ Hyperthyroidism: A Phase I Study. Thyroid. Jun 13 (2019)• Smith C, Hameed S, Rose GE, Wernig F: A 61 year old man with pancreatitis, pituitary dysfunction, and painful exophthalmos. BMJ, Feb 21 (2019)• Abbara A, Clarke S, Eng PC, Milburn J, Joshi D, Comninos AN, Ramli R, Mehta A, Jones B, Wernig F, Nair R, Mendoza N, Sam AH, Hatfield E, Meeran K, Dhillo WS, Martin NM: Clinical and biochemical characteristics of patients presenting with pituitary apoplexy. Endocr Connect. Aug 23 (2018), pii 18-0255.• Maher M, Roncaroli F, Mendoza N, Meeran K, Canham N, Kosicka-Slawinska M, Bernhard B, Collier D, Drummond J, Skordilis K, Tufton N, Gontsarova A, Martin N, Korbonits M, Wernig F: A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma. Endocrinol Diabetes Metab Case Rep. Jul 21 (2018), pii 18-0078.• Wernig F, Jayasena C, Dhillo, WS: Carcinoid syndrome and neuroendocrine tumours. Endocrine Cancer. Medicine 45:9 (2017),543-546• A novel somatic mutation implicates ATP6V0D1 in proinsulin processing Parizad Avari, Pei Chia Eng, Ming Hu, Runzhi Chen, Natalija Popovic, Constantin Polychronakos, Duncan Spalding, Guy A Rutter, Nick Oliver, Florian Wernig Journal of the Endocrine Society, bvac196, https://doi.org/10.1210/jendso/bvac196
Published 29 December 2022• ArTisaN trial protocol: a single Centre, open-label, phase II trial of the safety and efficacy of TheraSphere selective internal radiation therapy (SIRT) in the treatment of inoperable metastatic (liver) neuroendocrine neoplasia (NENs).
Sharma R, Slater S, Evans J, Martinez M, Ward C, Izadi H, Wernig F, Thomas R.BMC Cancer. 2022 Jul 20;22(1):800. doi: 10.1186/s12885-022-09859-9.• Late-night salivary cortisol and cortisone should be the initial screening test for Cushing's syndrome.
Mohamed RS, Abuelgasim B, Barker S, Prabhudev H, Martin NM, Meeran K, Williams EL, Darch S, Matthew W, Tan T, Wernig F.Endocr Connect. 2022 Jun 27;11(7):e220050. doi: 10.1530/EC-22-0050. Print 2022 Jul 1.• A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases.
Yeoh P, Dwyer AA, Anghel E, Bouloux PM, Khoo B, Chew S, Wernig F, Carroll P, Aylwin SJB, Baldeweg SE, Drake W, Todd J, Mangena L, Grossman A.Int J Endocrinol. 2022 Feb 8;2022:7360282. doi: 10.1155/2022/7360282. eCollection 2022.• To block, or not to block … is it still the question? Effectiveness of alpha- and beta-blockade in phaeochromocytoma surgery: an institutional analysis.
Van Den Heede K, Paspala A, Chander N, Chidambaram S, Wernig F, Todd JF, DiMarco AN, Palazzo FF.Ann R Coll Surg Engl. 2022 Feb;104(2):138-143. doi: 10.1308/rcsann.2021.1077.• SDHC phaeochromocytoma and paraganglioma: A UK-wide case series.
Williams ST, Chatzikyriakou P, Carroll PV, McGowan BM, Velusamy A, White G, Obholzer R, Akker S, Tufton N, Casey RT, Maher ER, Park SM, Porteous M, Dyer R, Tan T, Wernig F, Brady AF, Kosicka-Slawinska M, Whitelaw BC, Dorkins H, Lalloo F, Brennan P, Carlow J, Martin R, Mitchell AL, Harrison R, Hawkes L, Newell-Price J, Kelsall A, Igbokwe R, Adlard J, Schirwani S, Davidson R, Morrison PJ, Chung TT, Bowles C, Izatt L.Clin Endocrinol (Oxf). 2022 Apr;96(4):499-512. doi: 10.1111/cen.14594. Epub 2021 Sep 24.• Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia.
Almazrouei R, Zaman S, Wernig F, Meeran K.Clin Med Insights Endocrinol Diabetes. 2021 Jun 22;14:11795514211025276. doi: 10.1177/11795514211025276. eCollection 2021.• Alameri, M., Alnuaimi, A., Martin, N. M., Meeran, K., Gontsarova, A., Barwick, T. D., . . . Wernig, F. (2024). Pituitary hypophysitis in granulomatosis with polyangiitis (GPA): a case series.. Pituitary. doi:10.1007/s11102-023-01378-5 Wernig, F., Dunin-Borkowska, A., Frisiras, A., Khoo, B., Todd, J., Di Marco, A., . . . Alsafi, A. (2024). Adrenal Vein Sampling: Does the Location of the Non-adrenal Venous Sample Matter?. Cardiovasc Intervent Radiol. doi:10.1007/s00270-023-03647-z Chidambaram, S., Van Den Heede, K., Damji, S., Meeran, K., Todd, J., Wernig, F., . . . Di Marco, A. N. (2023). The Impact of Obesity on the Resolution of Hypertension Following Adrenalectomy for Primary Hyperaldosteronism. WORLD JOURNAL OF SURGERY, 47(9), 2188-2196. doi:10.1007/s00268-023-07021-5 Mills, E. G., Palazzo, F. F., Leen, E., & Wernig, F. (2023). Emerging Potential of Microwave Ablation for Primary Aldosteronism Resulting From Unilateral Aldosterone-producing Adenoma.. JCEM Case Rep, 1(4), luad077. doi:10.1210/jcemcr/luad077 Avari, P., Eng, P. C., Hu, M., Chen, R., Popovic, N., Polychronakos, C., . . . Wernig, F. (2023). A Novel Somatic Mutation Implicates ATP6V0D1 in Proinsulin Processing. JOURNAL OF THE ENDOCRINE SOCIETY, 7(3), 5 pages. doi:10.1210/jendso/bvac196 Sharma, R., Slater, S., Evans, J., Martinez, M., Ward, C., Izadi, H., . . . Thomas, R. (2022). ArTisaN trial protocol: a single Centre, open-label, phase II trial of the safety and efficacy of TheraSphere selective internal radiation therapy (SIRT) in the treatment of inoperable metastatic (liver) neuroendocrine neoplasia (NENs). BMC CANCER, 22(1), 7 pages. doi:10.1186/s12885-022-09859-9 Mohamed, R. S., Abuelgasim, B., Barker, S., Prabhudev, H., Martin, N. M., Meeran, K., . . . Wernig, F. (2022). Late-nigh salivary cortisol and cortisone should be the initial screening test for Cushing's syndrome. ENDOCRINE CONNECTIONS, 11(7), 7 pages. doi:10.1530/EC-22-0050 Almazrouei, R., Zaman, S., Wernig, F., & Meeran, K. (2021). Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia. CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 14, 7 pages. doi:10.1177/11795514211025276 Williams, S. T., Chatzikyriakou, P., Carroll, P. V., McGowan, B. M., Velusamy, A., White, G., . . . Izatt, L. (2022). SDHC phaeochromocytoma and paraganglioma: A UK-wide case series. CLINICAL ENDOCRINOLOGY, 96(4), 499-512. doi:10.1111/cen.14594 Yeoh, P., Dwyer, A. A., Anghel, E., Bouloux, P. M., Khoo, B., Chew, S., . . . Grossman, A. (2022). A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2022, 8 pages. doi:10.1155/2022/7360282 Van Den Heede, K., Paspala, A., Chander, N., Chidambaram, S., Wernig, F., Todd, J. F., . . . Palazzo, F. F. (2022). To block, or not to block … is it still the question? Effectiveness of alpha- and beta-blockade in phaeochromocytoma surgery: an institutional analysis.. Ann R Coll Surg Engl, 104(2), 138-143. doi:10.1308/rcsann.2021.1077 Van Den Heede, K., Paspala, A., Chander, N., Chidambaram, S., Wernig, F., Todd, J. F., . . . Palazzo, F. F. (2022). To block, or not to block ... is it still the question? Effectiveness of alpha- and beta-blockade in phaeochromocytoma surgery: an institutional analysis. ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 104(2), 138-143. doi:10.1308/rcsann.2021.0133 Wernig, F., Jayasena, C. N., & Dhillo, W. S. (2021). Carcinoid syndrome and neuroendocrine tumours. Medicine, 49(9), 544-547. doi:10.1016/j.mpmed.2021.06.004 Zaman, S., Almazrouei, R., Sam, A. H., DiMarco, A. N., Todd, J. F., Palazzo, F. F., . . . Wernig, F. (2021). Synacthen Stimulation Test Following Unilateral Adrenalectomy Needs to Be Interpreted With Caution. FRONTIERS IN ENDOCRINOLOGY, 12, 7 pages. doi:10.3389/fendo.2021.654600• Mohamed, R. S., Abuelgasim, B., Barker, S., Prabhudev, H., Martin, N. M., Meeran, K., . . . Wernig, F. (2022). Late-nigh salivary cortisol and cortisone should be the initial screening test for Cushing's syndrome. ENDOCRINE CONNECTIONS, 11(7), 7 pages. doi:10.1530/EC-22-0050• Sharma, R., Slater, S., Evans, J., Martinez, M., Ward, C., Izadi, H., . . . Wernig, F, Thomas, R. (2022). ArTisaN trial protocol: a single Centre, open-label, phase II trial of the safety and efficacy of TheraSphere selective internal radiation therapy (SIRT) in the treatment of inoperable metastatic (liver) neuroendocrine neoplasia (NENs). BMC CANCER, 22(1), 7 pages. doi:10.1186/s12885-022-09859-9• Avari, P., Eng, P. C., Hu, M., Chen, R., Popovic, N., Polychronakos, C., . . . Wernig, F. (2023). A Novel Somatic Mutation Implicates ATP6V0D1 in Proinsulin Processing. JOURNAL OF THE ENDOCRINE SOCIETY, 7(3), 5 pages. doi:10.1210/jendso/bvac196• Mills, E. G., Palazzo, F. F., Leen, E., & Wernig, F. (2023). Emerging Potential of Microwave Ablation for Primary Aldosteronism Resulting From Unilateral Aldosterone-producing Adenoma.. JCEM Case Rep, 1(4), luad077. doi:10.1210/jcemcr/luad077• Chidambaram, S., Van Den Heede, K., Damji, S., Meeran, K., Todd, J., Wernig, F., . . . Di Marco, A. N. (2023). The Impact of Obesity on the Resolution of Hypertension Following Adrenalectomy for Primary Hyperaldosteronism. WORLD JOURNAL OF SURGERY, 47(9), 2188-2196. doi:10.1007/s00268-023-07021-5• Wernig, F., Dunin-Borkowska, A., Frisiras, A., Khoo, B., Todd, J., Di Marco, A., . . . Alsafi, A. (2024). Adrenal Vein Sampling: Does the Location of the Non-adrenal Venous Sample Matter?. Cardiovasc Intervent Radiol. doi:10.1007/s00270-023-03647-z• Alameri, M., Alnuaimi, A., Martin, N. M., Meeran, K., Gontsarova, A., Barwick, T. D., . . . Wernig, F. (2024). Pituitary hypophysitis in granulomatosis with polyangiitis (GPA): a case series.. Pituitary. doi:10.1007/s11102-023-01378-5
...
All reviews are from real patients and have been verified by our Client Relations department to ensure they meet the service standards.
Patient reviews
P. Verified Patient
07/06/2022
Would you recommend this doctor?
Patients comments
Very professional and knowledgeable. Dr Wernig took his time to listen to my symptoms and gave me many options to consider. He also has a very holistic approach to treatment. I would definitely recommend him to friends and family.
P C. Verified Patient
07/06/2022
Would you recommend this doctor?
Patients comments
Dr Wernig filled me with full confidence and indeed four weeks on the recommended surgery has been completed to full satisfaction.
D M. Verified Patient
07/06/2022
Would you recommend this doctor?
Patients comments
I was seen very quickly by Dr Wernig, who gave a very clear explanation of the problem and the proposed solution. It was a very satisfying consultation.
C G. Verified Patient
07/06/2022
Would you recommend this doctor?
Patients comments
Dr Wernig was very professional whilst at the same time warm and compassionate. He is a good communicator and took the time to listen as well as inform. I left my consultation feeling as though I’d been heard and with a clearer idea of the path forward.